![R. Lee Douglas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of R. Lee Douglas
Former positions of R. Lee Douglas
Companies | Position | Start | End |
---|---|---|---|
FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 01/01/2002 | 10/05/2017 |
Founder | 01/01/2002 | 10/05/2017 | |
Independent Dir/Board Member | 01/01/2002 | 10/05/2017 | |
AFFYMAX, INC. | Director/Board Member | 01/01/2004 | 25/05/2011 |
COR Therapeutics, Inc.
![]() COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Founder | 01/01/1988 | 01/01/1998 |
Corporate Officer/Principal | 01/01/1988 | 01/01/1998 | |
Aerovance, Inc.
![]() Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Director/Board Member | - | - |
Calistoga Pharmaceuticals, Inc.
![]() Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Director/Board Member | 01/01/2008 | - |
Training of R. Lee Douglas
The University of North Carolina at Charlotte | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistics
International
United States | 8 |
Operational
Director/Board Member | 4 |
Founder | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AFFYMAX, INC. | Health Technology |
Private companies | 4 |
---|---|
Five Prime Therapeutics, Inc.
![]() Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
COR Therapeutics, Inc.
![]() COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Calistoga Pharmaceuticals, Inc.
![]() Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Health Technology |
Aerovance, Inc.
![]() Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
- Stock Market
- Insiders
- R. Lee Douglas
- Experience